Institutional Governance · ClinRegs LBR-18
REC Organization Structure, Quorum Thresholds & Review Pathways
How multidisciplinary Research Ethics Committees structure voting quorums, scientific vs. lay representation, and Full Board vs. Expedited protocol triage.
Under the Liberia National Research Ethics Board (NREB) statutory structure indexed in NIH ClinRegs (LBR-18), valid Full Board clinical trial approvals require a 21-member multidisciplinary committee operating with a simple majority quorum of at least 11 voting members, including at least one non-scientific member and one member unaffiliated with the host institution.
Primary reference: NIH NIAID ClinRegs Liberia Update & WHO Standards for Ethics Committees.
Board Composition & Multidisciplinary Representation
Independent ethical review fails when a committee consists solely of clinical investigators from the sponsoring hospital. Modern national ethics architectures balance biomedical expertise with legal, ethical, and community perspectives so that scientific enthusiasm never overrides participant welfare.
In the documented 21-member NREB-LR governance framework, seats are distributed across five functional cohorts: clinical and biomedical scientists, biostatisticians or pharmacologists, bioethicists and legal counsel, Ministry of Health or regulatory liaisons, and non-scientific community or faith representatives. Every voting member signs an annual conflict-of-interest attestation and recuses themselves from any protocol in which they serve as investigator, advisor, or sponsor consultant.
Quorum Mechanics & Voting Independence
A committee meeting cannot issue binding ethical clearance unless quorum rules are satisfied at the moment of the vote, not merely at roll call. If an investigator member recuses themselves mid-session and attendance drops below 11 voting members, deliberation must pause or defer to the next convened cycle.
| Jurisdiction / Standard | Board Size | Minimum Quorum | Non-Scientific / Lay Rule | Convened Cycle |
|---|---|---|---|---|
| Liberia NREB (LBR-18) | 21 members | 11 members (>50%) | ≥1 non-scientific & ≥1 unaffiliated | Monthly (28-42d SLA) |
| US 45 CFR 46 / FDA | ≥5 members | Majority (≥3) | ≥1 non-scientific & ≥1 unaffiliated | Bi-weekly / Monthly |
| ICH-GCP E6(R3) Baseline | ≥5 members | Majority present | ≥1 non-scientific & ≥1 independent | Risk-proportionate |
| WHO / CIOMS 2016 | 7-21 members | 50% + 1 | Gender balance + community voice | Monthly / PHEIC fast-track |
Interactive REC Review Pathway & Submission Dossier Checklist
Select your study design, participant cohort, and operational footprint to determine the required review pathway, quorum baseline, and mandatory filing documents.
Clinical Trial Protocol Review Standards
Full Board review is mandatory for all interventional Phase I-III drug, vaccine, and biologic trials, studies involving placebo controls, and protocols enrolling pediatric, pregnant, or emergency-consent cohorts. Expedited review by the Chair and two designated reviewers applies strictly to minimal-risk observational studies, anonymized secondary chart reviews, and minor administrative protocol amendments that do not alter participant risk.
Standardized Submission Dossier & Protocol Templates
To prevent administrative screening holds, sponsors and principal investigators must assemble a synchronized dossier before the monthly submission cutoff: the completed Initial Review Application Form, full study protocol with version control, plain-language Informed Consent Form (ICF), Investigator's Brochure, current GCP training certificates, clinical trial indemnity insurance, and a signed Material Transfer Agreement (MTA) whenever biological samples cross borders.
Historical Citation Archive (NIH ClinRegs LBR-18 Context)
This route preserves the historical structural reference previously hosted at nreblr.net/organization-structure/ and cited by NIH NIAID ClinRegs under identifier LBR-18 (National Research Ethics Board of Liberia). The current site operates as an independent biomedical ethics reference repository and does not process official government submissions.